mushroom poisoning

(redirected from GI symptoms)
Also found in: Dictionary, Thesaurus, Encyclopedia.

Mushroom Poisoning



Mushroom poisoning refers to the severe and often deadly effects of various toxins that are found in certain types of mushrooms. One type known as Amanita phalloides, appropriately called "death cap," accounts for the majority of cases. The toxins initially cause severe abdominal cramping, vomiting, and watery diarrhea, and then lead to liver and kidney failure.


The highest reported incidences of mushroom poisoning occur in western Europe, where a popular pastime is amateur mushroom hunting. Since the 1970s, the United States has seen a marked increase in mushroom poisoning due to an increase in the popularity of "natural" foods, the use of mushrooms as recreational hallucinogens, and the gourmet qualities of wild mushrooms. About 90% of the deaths due to mushroom poisoning in the United States and western Europe result from eating Amanita phalloides. This mushroom is recognized by its metallic green cap (the color may vary from light yellow to greenish brown), white gills (located under the cap), white stem, and bulb-shaped structure at the base of the stem. A pure white variety of this species also occurs. Poisoning results from ingestion of as few as one to three mushrooms. Higher death (mortality) rates of more than 50% occur in children less than 10 years of age.

Causes and symptoms

Poisonous mushrooms contain at least two different types of toxins, each of which can cause death if taken in large enough quantities. Some of the toxins found in poisonous mushrooms are among the most potent ever discovered. One group of poisons, known as amatoxins, blocks the production of DNA, the basis of cell reproduction. This leads to the death of many cells, especially those that reproduce frequently such as in the liver, intestines, and kidney. Other mushroom poisons affect the proteins needed for muscle contraction, and therefore reduce the ability of certain muscle groups to perform.
Symptoms of Amanita poisoning occur in different stages or phases. These include:
  • First phase. Abdominal cramping, nausea, vomiting, and severe watery diarrhea occur anywhere from 6-24 hours after eating the mushroom and last for about 24 hours. These intestinal symptoms can lead to dehydration and low blood pressure (hypotension).
  • Second phase. A period of remission of symptoms that lasts 1-2 days. During this time, the patient feels better, but blood tests begin to show evidence of liver and kidney damage.
  • Third phase. Liver and kidney failure develop at this point and either lead to death within about a week or recovery within 2-3 weeks.
Other symptoms are due to either a decrease in blood clotting factors that leads to internal bleeding or reduced muscle function, with the development of weakness and paralysis.


In most cases, the fact that the patient has recently eaten wild mushrooms is the clue to the cause of symptoms. Moreover, the identification of any remaining mushrooms by a qualified mushroom specialist (mycologist) can be a key to diagnosis. When in doubt, the toxin known as alpha-amantin can be found in the blood, urine, or stomach contents of an individual who has ingested poisonous Amanita mushrooms.


It is important to remember that there is no specific antidote for mushroom poisoning. However, several advances in therapy have decreased the death rate over the last several years. Early replacement of lost body fluids has been a major factor in improving survival rates.
Therapy is aimed at decreasing the amount of toxin in the body. Initially, attempts are made to remove toxins from the upper gastrointestinal tract by inducing vomiting or by gastric lavage (stomach pumping). After that continuous aspiration of the upper portion of the small intestine through a nasogastric tube is done and oral charcoal (every four hours for 48 hours) is given to prevent absorption of toxin. These measures work best if started within six hours of ingestion.
In the United States, early removal of mushroom poison by way of an artificial kidney machine (dialysis) has become part of the treatment program. This is combined with the correction of any imbalances of salts (electrolytes) dissolved in the blood, such as sodium or potassium. An enzyme called thioctic acid and corticosteroids also appear to be beneficial, as well as high doses of penicillin. In Europe, a chemical taken from the milk thistle plant, Silybum marianum, is also part of treatment. When liver failure develops, liver transplantation may be the only treatment option.


The mortality rate has decreased with improved and rapid treatment. However, according to some medical reports death still occurs in 20-30% of cases, with a higher mortality rate of 50% in children less than 10 years old.


The most important factor in preventing mushroom poisoning is to avoid eating wild or noncultivated mushrooms. For anyone not expert in mushroom identification, there are generally no easily recognizable differences between nonpoisonous and poisonous mushrooms. It is also important to remember that most mushroom poisons are not destroyed or deactivated by cooking, canning, freezing, drying, or other means of food preparation.



"Alerts from the CDC." Experience Lab Page. 〈〉.
"Cyclopeptide-Containing Mushroom Toxicity." The Toxikon Multimedia Project Page.
"Mushroom Poisoning in Children." American Association of Family Physicians. 〈〉.
Mushroom Toxins from the FDA. 〈http://vm.cfsan.fda.-gov/∼mow/chap40.html〉.
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.


the fruiting body of any of a variety of fleshy fungi of the order Agaricales, especially one that is edible. Poisonous species are popularly called toadstools.
mushroom poisoning poisoning resulting from ingestion of mushrooms; potentially deadly mushrooms include Amanita phalloides, A. verna, A. virosa, and certain other species that contain neurotoxins. Rapid identification of mushroom poisoning and treatment is critical. According to the Center for Food Safety and Applied Nutrition of the Food and Drug Administration, persons who have ingested poisonous mushrooms and are treated immediately have a mortality rate of 10 per cent, whereas those who are treated 60 or more hours later have a 60 to 90 per cent mortality rate.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.


, mycetismus (mī'sē-tizm, -tiz'mŭs),
Poisoning by certain species of mushrooms.
Synonym(s): muscarinism
[G. mykēs, fungus]
Farlex Partner Medical Dictionary © Farlex 2012

mushroom poisoning

Toxicology Intoxication with substances derived from mushrooms, which are divided into those of rapid and delayed onset
Mushroom intoxication
Rapid-onset symptoms
GI symptoms, due to unknown toxins; onset within 1-3 hrs of ingestion, most commonly due to Chlorophyllum molybdites–aka Lepiota morgani, characterized by severe vomiting and diarrhea
Alcohol sensitization, due to coprine, which results in an Antabuse-like reaction, which affects the ingestant for up to 5 days after mushroom intake, most commonly due to Coprinus atramentarium, the symptoms include face flushing, tingling of fingers, and a metallic taste in mouth
PSL syndrome A symptom complex occurring 15 mins to 1 hr after ingesting the mushroom and characterized by perspiration, salivation, and lacrimation, caused by muscarine, a cholinergic toxin, which is accompanied by vomiting, diarrhea, and ↑ urination; most commonly due to Inocybe spp, Clitocybe spp, and others; antidote atropine
Hallucinogenic effect Toxins psilocybin and psilocin; symptoms begin 15 mins to 3 hrs after ingesting Psilocybe spp and others, and include delusions, euphoria, anxiety, distortion of the time-space continuum, and seizures, most commonly in children
Intoxication/delirium Toxins ibotenic acid/muscimol; symptoms begin 30 mins to 2 hrs after ingesting Amanita muscaria and others, and include apparent intoxication, incoordination, hyperactivity, muscle spasms, collapse, anxiety, altered vision, vomiting, and a coma-like state
Delayed-onset symptoms  
GI/headache/liver damage Toxin monomethylhydrazine–MMH; symptoms begin within 6-12 hrs of ingestion, and include bloating, nausea, vomiting, diarrhea, abdominal pain, muscle cramps, and vertigo; MMH is present in Gyromitra esculenta
GI/liver damage Toxin amatoxin; symptoms occur in three stages: 12-24 hrs with nausea and severe abdominal pain, followed by a short period in which the symptoms appear to remit, followed by a resumption of symptoms, and fatal–in up to 50% of cases liver failure in 4-7 days; amatoxins are present in Amanita phylloides, and other Amanita spp
Kidney/liver damage Toxin orellanine; symptoms are delayed, beginning between 36 hrs and 14 days, and include extreme thirst, ↑ urinary frequency, lumbar pain, chills or fever, diarrhea or constipation  
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.


, mycetismus (mī'sĕ-tizm,-tiz'mŭs)
Poisoning by certain species of mushrooms.
[G. mykēs, fungus]
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
Interestingly, we found that as the cortisol levels went up in response to the stress test, so did the child's GI symptoms, especially for constipation.
All young patients aged 18-40 years of age with IDA having GI symptoms who underwent upper and/or lower GI endoscopies between July 2016 to December 2016 at Aga Khan University Hospital Karachi were included in the study and patients having active bleeding (per rectal bleed, haematemesis, melena, epistaxis and menorrhagia) were excluded.
A history of fever and GI symptoms and a long career duration were associated with SFTSV seroprevalence.
FODMAPs may be a causative factor in GI symptoms and to some extent in extraintestinal symptoms such as fatigue and loss of vitality in some NCGS patients.
GSRS evaluates a wide range of GI symptoms. The questionnaire contains 15 items which are combined into five symptom clusters, namely, reflux, abdominal pain, indigestion, diarrhoea, and constipation [48].
If a patient presents with these non-specific GI symptoms along with raised INR and low Haemoglobin in postoperative follow up, one must investigate to rule out significant pericardial effusion.
Constipation was also self-evaluated during the whole study period using a diary where the patients indicated the numbers of bowel movements, sense of incomplete evacuation (yes/no), straining at defecation (yes/no), number of ineffective defecation attempts, help for defecation (laxatives, suppositories, enema, and digitations), associated GI symptoms (mild, moderate, and severe), and impairment of daily activities.
Even though we cannot say with absolute certainty that our patient met diagnostic criteria for CWS, marijuana did play a significant role in her day-to-day life, and her use escalated in recent years to help control GI symptoms. One wonders what role cannabis would have played in her life if Addison's disease had been diagnosed earlier on.
These findings are important as these patients are more likely to present with metastatic symptoms including GI symptoms than testicular mass or swelling.
'Although it is beyond the scope of this review, it is also important to consider the mechanisms by which psychotherapies improve GI symptoms and to determine the 'active ingredients' responsible for this effect."
It was further observed that all GI symptoms were more prevalent in patients aging 1-8 and 19-50 years.
Her GI symptoms were initially attributed to side effects of antibiotic treatment for cellulitis and dyspepsia before investigating her with a colonoscopy.